George Schreiner

Dr. Schreiner was the founding Chief Executive Officer/President of Epirium Bio and currently serves as the Chief Scientific Officer. His career has been grounded in basic and clinical biomedical science, drug development and corporate strategic development. After serving on the faculty at Harvard Medical School and the University of Washington School of Medicine, he was a founding scientist and vice president of CV Therapeutics. He also held senior management positions at Scios, Johnson & Johnson and Raven Biotechnologies. Dr. Schreiner has been awarded 21 patents and is the author of more than 140 scientific publications. He received an M.D. and Ph.D. from Harvard University.